insights_auto
Why is PTX down 3.03%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.064
arrow_downward
-3.03%(-0.0020) 1D
Oct 5, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
69.02M
Avg. vol.
1.19M
Volume
0.00
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
69.02M
Avg. vol.
1.19M
Volume
0.00
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
TradingView
·
1 hour ago
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction
Seeking Alpha
·
15 minutes ago
Record 72 S&P 500 firms issue positive Q3 earnings guidance - FactSet (SPY:NYSEARCA)
marketscreener.com
·
4 hours ago
Stifel lifts year-end target for S&P 500 to 7,900
FXEmpire
·
27 minutes ago
Nasdaq Index: Big Tech and Software Deals Drive Fresh Record High
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com